Use of 2% propofol to produce diurnal sedation in critically ill patients

G. McLeod (Lead / Corresponding author), C. Wallis, J. Dick, C. Cox, A. Patterson, J. Colvin

    Research output: Contribution to journalArticle

    13 Citations (Scopus)

    Abstract

    Objective: The assessment of propofol to produce diurnal sedation in critically ill patients. Design: Prospective clinical study Setting: Intensive Care Unit, University Hospital. Patients and participants: Thirty consecutive patients admitted to the Intensive Care Unit older than 18 years who were expected to be sedated for more than 50 h. Interventions: The patients were randomised into two groups. All received sedation with a constant background infusion of morphine and a variable infusion rate of propofol, which was altered hourly to maintain the intended sedation score. The first group received constant light sedation (CLS) over 50 h aiming for a Ramsay score of 2-3. The second group received CLS between 0600 h and 2200 h and additional night sedation (ANS) with propofol between 2200 h and 0600 h, aiming for a sedation score of 4-5. Measurements and results: Patients were studied for 50 h from 1800 h on the first day of admission. Recordings of heart rate, blood pressure, sedation scores and propofol and morphine infusion rates were made hourly. An APACHE II score was recorded for each patient. Sedation scores were analysed by blind visual assessment and cosinor analysis, which is used in chronobiology to examine the correlation of data with a cosine curve. Patients in the ANS group had significantly better rhythmicity of sedation levels using cosinor analysis (r = 26% v 8%) p <0.01. There was no difference between the CLS and ANS groups with respect to age, sex or APACHE II scores. Nine out of 15 patients in the ANS group achieved diurnal sedation. Three patients in the CLS group showed diurnal rhythmicity of sedation, which can be attributed to natural sleep, and had a median APACHE II score of 12. Five patients in the CLS group and three in the ANS group showed a deep constant sedation pattern. They had high APACHE II scores (median 21.5) and an obtunded conscious level on admission due to severe sepsis. Conclusion: Propofol can safely provide diurnal sedation in the critically ill when titrated against the Ramsay score. Sedation levels cannot be manipulated in some severely ill patients.
    Original languageEnglish
    Pages (from-to)428-434
    Number of pages7
    JournalIntensive Care Medicine
    Volume23
    Issue number4
    DOIs
    Publication statusPublished - Apr 1997

    Fingerprint

    Propofol
    Critical Illness
    APACHE
    Light
    Periodicity
    Morphine
    Intensive Care Units
    Deep Sedation
    Sepsis
    Sleep
    Heart Rate
    Prospective Studies
    Blood Pressure

    Cite this

    McLeod, G. ; Wallis, C. ; Dick, J. ; Cox, C. ; Patterson, A. ; Colvin, J. / Use of 2% propofol to produce diurnal sedation in critically ill patients. In: Intensive Care Medicine. 1997 ; Vol. 23, No. 4. pp. 428-434.
    @article{82d449bdb80340eca5e2e560b23b8025,
    title = "Use of 2{\%} propofol to produce diurnal sedation in critically ill patients",
    abstract = "Objective: The assessment of propofol to produce diurnal sedation in critically ill patients. Design: Prospective clinical study Setting: Intensive Care Unit, University Hospital. Patients and participants: Thirty consecutive patients admitted to the Intensive Care Unit older than 18 years who were expected to be sedated for more than 50 h. Interventions: The patients were randomised into two groups. All received sedation with a constant background infusion of morphine and a variable infusion rate of propofol, which was altered hourly to maintain the intended sedation score. The first group received constant light sedation (CLS) over 50 h aiming for a Ramsay score of 2-3. The second group received CLS between 0600 h and 2200 h and additional night sedation (ANS) with propofol between 2200 h and 0600 h, aiming for a sedation score of 4-5. Measurements and results: Patients were studied for 50 h from 1800 h on the first day of admission. Recordings of heart rate, blood pressure, sedation scores and propofol and morphine infusion rates were made hourly. An APACHE II score was recorded for each patient. Sedation scores were analysed by blind visual assessment and cosinor analysis, which is used in chronobiology to examine the correlation of data with a cosine curve. Patients in the ANS group had significantly better rhythmicity of sedation levels using cosinor analysis (r = 26{\%} v 8{\%}) p <0.01. There was no difference between the CLS and ANS groups with respect to age, sex or APACHE II scores. Nine out of 15 patients in the ANS group achieved diurnal sedation. Three patients in the CLS group showed diurnal rhythmicity of sedation, which can be attributed to natural sleep, and had a median APACHE II score of 12. Five patients in the CLS group and three in the ANS group showed a deep constant sedation pattern. They had high APACHE II scores (median 21.5) and an obtunded conscious level on admission due to severe sepsis. Conclusion: Propofol can safely provide diurnal sedation in the critically ill when titrated against the Ramsay score. Sedation levels cannot be manipulated in some severely ill patients.",
    author = "G. McLeod and C. Wallis and J. Dick and C. Cox and A. Patterson and J. Colvin",
    year = "1997",
    month = "4",
    doi = "10.1007/s001340050352",
    language = "English",
    volume = "23",
    pages = "428--434",
    journal = "Intensive Care Medicine",
    issn = "0342-4642",
    publisher = "Springer Verlag",
    number = "4",

    }

    McLeod, G, Wallis, C, Dick, J, Cox, C, Patterson, A & Colvin, J 1997, 'Use of 2% propofol to produce diurnal sedation in critically ill patients', Intensive Care Medicine, vol. 23, no. 4, pp. 428-434. https://doi.org/10.1007/s001340050352

    Use of 2% propofol to produce diurnal sedation in critically ill patients. / McLeod, G. (Lead / Corresponding author); Wallis, C.; Dick, J.; Cox, C.; Patterson, A.; Colvin, J.

    In: Intensive Care Medicine, Vol. 23, No. 4, 04.1997, p. 428-434.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Use of 2% propofol to produce diurnal sedation in critically ill patients

    AU - McLeod, G.

    AU - Wallis, C.

    AU - Dick, J.

    AU - Cox, C.

    AU - Patterson, A.

    AU - Colvin, J.

    PY - 1997/4

    Y1 - 1997/4

    N2 - Objective: The assessment of propofol to produce diurnal sedation in critically ill patients. Design: Prospective clinical study Setting: Intensive Care Unit, University Hospital. Patients and participants: Thirty consecutive patients admitted to the Intensive Care Unit older than 18 years who were expected to be sedated for more than 50 h. Interventions: The patients were randomised into two groups. All received sedation with a constant background infusion of morphine and a variable infusion rate of propofol, which was altered hourly to maintain the intended sedation score. The first group received constant light sedation (CLS) over 50 h aiming for a Ramsay score of 2-3. The second group received CLS between 0600 h and 2200 h and additional night sedation (ANS) with propofol between 2200 h and 0600 h, aiming for a sedation score of 4-5. Measurements and results: Patients were studied for 50 h from 1800 h on the first day of admission. Recordings of heart rate, blood pressure, sedation scores and propofol and morphine infusion rates were made hourly. An APACHE II score was recorded for each patient. Sedation scores were analysed by blind visual assessment and cosinor analysis, which is used in chronobiology to examine the correlation of data with a cosine curve. Patients in the ANS group had significantly better rhythmicity of sedation levels using cosinor analysis (r = 26% v 8%) p <0.01. There was no difference between the CLS and ANS groups with respect to age, sex or APACHE II scores. Nine out of 15 patients in the ANS group achieved diurnal sedation. Three patients in the CLS group showed diurnal rhythmicity of sedation, which can be attributed to natural sleep, and had a median APACHE II score of 12. Five patients in the CLS group and three in the ANS group showed a deep constant sedation pattern. They had high APACHE II scores (median 21.5) and an obtunded conscious level on admission due to severe sepsis. Conclusion: Propofol can safely provide diurnal sedation in the critically ill when titrated against the Ramsay score. Sedation levels cannot be manipulated in some severely ill patients.

    AB - Objective: The assessment of propofol to produce diurnal sedation in critically ill patients. Design: Prospective clinical study Setting: Intensive Care Unit, University Hospital. Patients and participants: Thirty consecutive patients admitted to the Intensive Care Unit older than 18 years who were expected to be sedated for more than 50 h. Interventions: The patients were randomised into two groups. All received sedation with a constant background infusion of morphine and a variable infusion rate of propofol, which was altered hourly to maintain the intended sedation score. The first group received constant light sedation (CLS) over 50 h aiming for a Ramsay score of 2-3. The second group received CLS between 0600 h and 2200 h and additional night sedation (ANS) with propofol between 2200 h and 0600 h, aiming for a sedation score of 4-5. Measurements and results: Patients were studied for 50 h from 1800 h on the first day of admission. Recordings of heart rate, blood pressure, sedation scores and propofol and morphine infusion rates were made hourly. An APACHE II score was recorded for each patient. Sedation scores were analysed by blind visual assessment and cosinor analysis, which is used in chronobiology to examine the correlation of data with a cosine curve. Patients in the ANS group had significantly better rhythmicity of sedation levels using cosinor analysis (r = 26% v 8%) p <0.01. There was no difference between the CLS and ANS groups with respect to age, sex or APACHE II scores. Nine out of 15 patients in the ANS group achieved diurnal sedation. Three patients in the CLS group showed diurnal rhythmicity of sedation, which can be attributed to natural sleep, and had a median APACHE II score of 12. Five patients in the CLS group and three in the ANS group showed a deep constant sedation pattern. They had high APACHE II scores (median 21.5) and an obtunded conscious level on admission due to severe sepsis. Conclusion: Propofol can safely provide diurnal sedation in the critically ill when titrated against the Ramsay score. Sedation levels cannot be manipulated in some severely ill patients.

    UR - http://www.scopus.com/inward/record.url?scp=0030909601&partnerID=8YFLogxK

    U2 - 10.1007/s001340050352

    DO - 10.1007/s001340050352

    M3 - Article

    VL - 23

    SP - 428

    EP - 434

    JO - Intensive Care Medicine

    JF - Intensive Care Medicine

    SN - 0342-4642

    IS - 4

    ER -